Doug Fisher

Doug joined Revelation Partners in 2020 as a Partner. He is currently a board member of WeavR Health, Precipio Diagnostics, and IndiMolecular. Since 2009, Doug has worked at InterWest Partners, as a Partner and Executive in Residence where he focused on biopharma and diagnostics investments. Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments, and prior to that he was a Project Leader at The Boston Consulting Group where he focused on the pharmaceutical consulting practice. Doug received an A.B. in economics with honors and distinction, and a B.S. in biology with distinction, from Stanford, where he graduated Phi Beta Kappa. He has an M.D. from the University of Pennsylvania School of Medicine and an M.B.A. from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.